Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

This side study investigated the effect of chemotherapy on thyroid function and the extent to which it can predict pathological complete response (pCR) in patients with early breast cancer taking part in NEOZOTAC phase III trial, randomizing between neoadjuvant chemotherapy with or without additiona...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, S., Janssen, L. G. M., Charehbili, A., Dijkgraaf, E. M., Smit, V. T. H. B. M., Kessels, L. W., van Bochove, A., van Laarhoven, H. W. M., Meershoek-Klein Kranenbarg, E., van Leeuwen-Stok, A. E., van de Velde, C. J. H., Putter, H., Nortier, J. W. R., van der Hoeven, J. J. M., Pijl, H., Kroep, J. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308642/
https://www.ncbi.nlm.nih.gov/pubmed/25556355
http://dx.doi.org/10.1007/s10549-014-3256-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308642/
https://www.ncbi.nlm.nih.gov/pubmed/25556355
http://dx.doi.org/10.1007/s10549-014-3256-4

Ejemplares similares